BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33252487)

  • 1. HIV-DNA content in pTfh cells is associated with residual viremia in elite controllers.
    García M; Morcilla V; Navarrete-Muñoz MÁ; Fisher K; Cabello A; López-Bernaldo JC; De La Hera F; Barros C; Fernández-Guerrero M; Estrada V; Górgolas M; Benito JM; Palmer S; Rallón N
    AIDS; 2021 Mar; 35(3):393-398. PubMed ID: 33252487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART.
    García M; Górgolas M; Cabello A; Estrada V; Ligos JM; Fernández-Guerrero M; Barros C; López-Bernaldo JC; De La Hera FJ; Montoya M; Benito JM; Rallón N
    Sci Rep; 2017 Dec; 7(1):16799. PubMed ID: 29196729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
    Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
    J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
    Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
    J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.
    Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V
    J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control.
    García M; López-Fernández L; Mínguez P; Morón-López S; Restrepo C; Navarrete-Muñoz MA; López-Bernaldo JC; Benguría A; García MI; Cabello A; Fernández-Guerrero M; De la Hera FJ; Estrada V; Barros C; Martínez-Picado J; Górgolas M; Benito JM; Rallón N
    J Mol Med (Berl); 2020 Aug; 98(8):1093-1105. PubMed ID: 32556382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
    de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
    Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Peripheral T Follicular Helper Cells in Perinatally HIV-Infected Children Correlate With Advancing HIV Disease.
    McCarty B; Mwamzuka M; Marshed F; Generoso M; Alvarez P; Ilmet T; Kravietz A; Ahmed A; Borkowsky W; Unutmaz D; Khaitan A
    Front Immunol; 2018; 9():1901. PubMed ID: 30197641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.
    Pereyra F; Palmer S; Miura T; Block BL; Wiegand A; Rothchild AC; Baker B; Rosenberg R; Cutrell E; Seaman MS; Coffin JM; Walker BD
    J Infect Dis; 2009 Sep; 200(6):984-90. PubMed ID: 19656066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid development of HIV elite control in a patient with acute infection.
    Morley D; Lambert JS; Hogan LE; De Gascun C; Redmond N; Rutishauser RL; Thanh C; Gibson EA; Hobbs K; Bakkour S; Busch MP; Farrell J; McGetrick P; Henrich TJ
    BMC Infect Dis; 2019 Sep; 19(1):815. PubMed ID: 31533639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers.
    Li JZ; Segal FP; Bosch RJ; Lalama CM; Roberts-Toler C; Delagreverie H; Getz R; Garcia-Broncano P; Kinslow J; Tressler R; Van Dam CN; Keefer M; Carrington M; Lichterfeld M; Kuritzkes D; Yu XG; Landay A; Sax PE;
    Clin Infect Dis; 2020 Apr; 70(8):1636-1642. PubMed ID: 31131858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.
    Hatano H; Delwart EL; Norris PJ; Lee TH; Dunn-Williams J; Hunt PW; Hoh R; Stramer SL; Linnen JM; McCune JM; Martin JN; Busch MP; Deeks SG
    J Virol; 2009 Jan; 83(1):329-35. PubMed ID: 18945778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
    Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
    Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
    Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X4-Tropic Latent HIV-1 Is Enriched in Peripheral Follicular Helper T Cells and Is Correlated with Disease Progression.
    Yu F; Li Q; Chen X; Liu J; Li L; Li B; Liu B; Zhang J; Zhang X; Liu Z; Luo H; Tang XP; Cai W; Zhang H; Deng K
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
    Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
    J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers.
    Dahl V; Peterson J; Spudich S; Lee E; Shacklett BL; Price RW; Palmer S
    AIDS; 2013 Apr; 27(7):1145-9. PubMed ID: 23211774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune escape mutations in HIV-1 controllers in the Brazilian Amazon region.
    Gomes STM; da Silva Graça Amoras E; Gomes ÉR; Queiroz MAF; Júnior ECS; de Vasconcelos Massafra JM; da Silva Lemos P; Júnior JLV; Ishak R; Vallinoto ACR
    BMC Infect Dis; 2020 Jul; 20(1):546. PubMed ID: 32711474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiretroviral therapy on HIV reservoirs in elite controllers.
    Chun TW; Shawn Justement J; Murray D; Kim CJ; Blazkova J; Hallahan CW; Benko E; Costiniuk CT; Kandel G; Ostrowski M; Kaul R; Moir S; Casazza JP; Koup RA; Kovacs C; Fauci AS
    J Infect Dis; 2013 Nov; 208(9):1443-7. PubMed ID: 23847057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.
    Hunt PW; Brenchley J; Sinclair E; McCune JM; Roland M; Page-Shafer K; Hsue P; Emu B; Krone M; Lampiris H; Douek D; Martin JN; Deeks SG
    J Infect Dis; 2008 Jan; 197(1):126-33. PubMed ID: 18171295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.